谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase 1b/2 Study Of Tak-659, An Investigational Dual Syk And Flt-3 Inhibitor, In Patients (Pts) With Relapsed Or Refractory Acute Myelogenous Leukemia (R/R Aml)

Jason B. Kaplan,Dale L. Bixby,John C. Morris,Olga Frankfurt,Jessica Altman,Trisha Wise-Draper,Patrick W. Burke,Sabrina Collins,Karuppiah Kannan,Ling Wang,Stephanie Faucette, Benjamin Lee,Yaping Shou,Mark J. Levis,Keith W. Pratz

BLOOD（2016）

引用 12|浏览12
暂无评分
摘要
Background
更多
查看译文
关键词
refractory acute myelogenous leukemia,investigational dual syk,inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要